MOTIVATION
The ligand/protein binding interaction is typically investigated by docking and molecular dynamics (MD) simulations. In particular, docking-based virtual screening (VS) is used to select the best ligands from database of thousands of compounds, while MD calculations assess the energy stability of the ligand/protein binding complexes. Considering the broad use of these techniques, it is of great demand to have one single software that allows a combined and fast analysis of VS and MD results. With this in mind, we have developed the Drug Discovery Tool (DDT) that is an intuitive graphics user interface able to provide structural data and physico-chemical information on the ligand/protein interaction.
RESULTS
DDT is designed as a plugin for the Visual Molecular Dynamics (VMD) software and is able to manage a large number of ligand/protein complexes obtained from AutoDock4 (AD4) docking calculations and MD simulations. DDT delivers 4 main outcomes: i) ligands ranking based on an energy score; ii) ligand ranking based on a ligands' conformation cluster analysis; iii) identification of the aminoacids forming the most occurrent interactions with the ligands; iv) plot of the ligands' center-of-mass coordinates in the cartesian space. The flexibility of the software allows saving the best ligand/protein complexes using a number of user-defined options.
AVAILABILITY
DDT_site_1 (alternative DDT_site_2); the DDT tutorial movie is available clicking here.
SUPPLEMENTARY INFORMATION
Supplementary data are available at Bioinformatics online.
[1]
David S. Goodsell,et al.
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
,
2009,
J. Comput. Chem..
[2]
V. Sepe,et al.
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors.
,
2014,
Journal of medicinal chemistry.
[3]
K Schulten,et al.
VMD: visual molecular dynamics.
,
1996,
Journal of molecular graphics.
[4]
S. Marchianò,et al.
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1
,
2019,
Scientific Reports.
[5]
Berk Hess,et al.
GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers
,
2015
.
[6]
Leslie A. Leinwand,et al.
The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity
,
2012,
Nature.